Postoperative nesiritide use following high-risk mitral valve replacement.
Publication/Presentation Date
1-1-2004
Abstract
Nesiritide is primarily used in the treatment of acutely decompensated chronic heart failure. It may also be useful in the postoperative management of patients with an exacerbation of heart failure after cardiac surgery. The management of a patient with cardiogenic shock after acute papillary muscle rupture is described. The patient exhibited signs of postoperative heart failure, and nesiritide therapy was instituted to lower filling pressures and achieve diuresis. This drug may be useful when patients with heart failure undergo cardiac surgery and continue to show evidence of heart failure in the postoperative period.
Volume
7
Issue
3
First Page
189
Last Page
190
ISSN
1522-6662
Published In/Presented At
Entwistle, J. W., 3rd, McLoughlin, D. E., & Baghelai, K. (2004). Postoperative nesiritide use following high-risk mitral valve replacement. The heart surgery forum, 7(3), E189–E190. https://doi.org/10.1532/HSF98.20033008
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
15262599
Department(s)
Administration and Leadership
Document Type
Article